Real-World Outcomes in Patients with EGFR/ALK-Positive NSCLC Treated with Chemotherapy Following 1 or 2 Lines of TKI Therapy

被引：0
|
作者：
Cheema, P. [1 ]
Ton, T. [2 ]
Lambert, P. [2 ]
Merritt, D. [3 ]
Morris, S. [3 ]
Shankar, G. [2 ]
Ganti, A. K. [4 ,5 ]
机构：
[1] Univ Toronto, William Osler Hlth Syst, Toronto, ON, Canada
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] F Hoffmann La Roche Ltd, Basel, Switzerland
[4] VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA
[5] Univ Nebraska Med Ctr, Omaha, NE USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TT01.01
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Characteristics and Outcomes of Hispanic Patients with RET-Fusion Positive NSCLC Treated in Real-World Practice
    Arrieta, O.
    Cardona, A.
    Cordeiro de Lima, V. C.
    Figueiredo Saldanha, E.
    Corrales, L.
    Freitas, H.
    Gil-Santana, L.
    Martin, C.
    Enrico, D.
    Motta, R.
    Rojas, L.
    Zuluaga, J.
    Viola, L.
    Martinez, S.
    Cruz, G.
    Valencia, A.
    Raez, L.
    Rolfo, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S357 - S358
  • [32] Real-World Outcomes of 2L ALK TKIs Following 1L Brigatinib for Patients with ALK plus NSCLC from the ALTA-1L Trial
    Ahn, M. -J.
    Delmonte, A.
    Ghosh, S.
    Hochmair, M.
    Yang, T. -Y.
    Yang, J. C. -H.
    Han, J. -Y.
    Hansen, K. Holmskov
    Wu, Y.
    Wan, Y.
    Lin, H. M.
    Kretz, J.
    Hupf, B.
    Kurec, A. M.
    Churchill, E. N.
    Fram, R. J.
    Cabasag, C. J.
    Goriya, V.
    Zhao, Y.
    Gemmen, E.
    Campelo, M. R. Garcia
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S200 - S200
  • [33] Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
    Reale, M. L.
    Scattolin, D.
    Bria, E.
    Vitale, A.
    Grisanti, S.
    Costa, J.
    Galetta, D.
    Sini, C.
    Minuti, G.
    Citarella, F.
    Roca, E.
    Agustoni, F.
    Tiseo, M.
    Cortinovis, D. L.
    Pilotto, S.
    Ricciardi, S.
    Passiglia, F.
    Malapelle, U.
    Novello, S.
    Pasello, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S818 - S818
  • [34] ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study
    Wang, Michelle
    Slatter, Shadera
    Sussell, Jesse
    Lin, Chia-Wei
    Ogale, Sarika
    Datta, Debajyoti
    Butte, Atul J.
    Bazhenova, Lyudmila
    Rudrapatna, Vivek A.
    TARGETED ONCOLOGY, 2023, 18 (04) : 571 - 583
  • [35] ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study
    Michelle Wang
    Shadera Slatter
    Jesse Sussell
    Chia-Wei Lin
    Sarika Ogale
    Debajyoti Datta
    Atul J. Butte
    Lyudmila Bazhenova
    Vivek A. Rudrapatna
    Targeted Oncology, 2023, 18 : 571 - 583
  • [36] Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience
    Rupp, Martin
    Fanton-Aita, Fiorella
    Snow, Stephanie
    Wheatley-Price, Paul
    Melosky, Barbara
    Juergens, Rosalyn A. A.
    Chu, Quincy
    Blais, Normand
    Banerji, Shantanu
    Ng, Ryan
    Khoudigian, Shoghag
    Sharma, Arushi
    On, Phu Vinh
    Liu, Geoffrey
    CURRENT ONCOLOGY, 2023, 30 (07) : 6559 - 6574
  • [37] Clinical profile, practice pattern and outcomes in ALK-positive lung cancer: Real-world data from India
    Kapoor, A.
    Noronha, V.
    Patil, M.
    Joshi, A. S.
    Menon, N.
    Kumar, R.
    Mahajan, A.
    Prabhash, K.
    Janu, A.
    Chougule, A.
    Shetty, O.
    ANNALS OF ONCOLOGY, 2020, 31 : S1400 - S1400
  • [38] Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
    Ou, Sai-Hong Ignatius
    Lin, Huamao M.
    Hong, Jin-Liern
    Yin, Yu
    Jin, Shu
    Lin, Jianchang
    Mehta, Minal
    Nguyen, Danny
    Neal, Joel W.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (10):
  • [39] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
    Luo, Yung-Hung
    Liu, Han
    Wampfler, Jason A.
    Tazelaar, Henry D.
    Li, Yalun
    Peikert, Tobias
    Liu, Dan
    Leventakos, Konstantinos
    Chen, Yuh-Min
    Yang, Yanan
    Chiou, Shih-Hwa
    Yang, Ping
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2099 - 2114
  • [40] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
    Yung-Hung Luo
    Han Liu
    Jason A. Wampfler
    Henry D. Tazelaar
    Yalun Li
    Tobias Peikert
    Dan Liu
    Konstantinos Leventakos
    Yuh-Min Chen
    Yanan Yang
    Shih-Hwa Chiou
    Ping Yang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2099 - 2114
12345